SHPHF

Sihuan Pharmaceutical Holdings Group Ltd.

USD

Set alert

Price alert · SHPHF

All alert types
0.21 USD +0.04 +23.71%
As of Feb 5, 2026
0.235 Day range 0.235
0.10 52-week range 0.235
YTD
+31.44%
1 year
+327.44%
Open
0.235
Prev close
0.17
Mkt cap
1.92B
Vol
50
Avg vol
0
EPS
0.00
P/E
0.00
More statistics
Low
0.235
High
0.235

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for SHPHF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

1.68 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 59.2×
FY 2016: 10.6×FY 2017: 14.7×FY 2018: 6.5×FY 2019: -2.4×FY 2020: 9.7×FY 2021: 23.0×FY 2022: -3.3×FY 2023: -97.9×FY 2024: -15.3×FY 2025: 59.2×
FY 2016 5y median -3.3× FY 2025
P/S 4.0×
FY 2016: 5.7×FY 2017: 7.6×FY 2018: 3.6×FY 2019: 2.3×FY 2020: 2.0×FY 2021: 3.2×FY 2022: 3.0×FY 2023: 2.8×FY 2024: 1.8×FY 2025: 4.0×
FY 2016 5y median 3.0× FY 2025
P/B 1.7×
FY 2016: 1.7×FY 2017: 1.9×FY 2018: 0.8×FY 2019: 0.7×FY 2020: 0.5×FY 2021: 1.2×FY 2022: 1.4×FY 2023: 1.2×FY 2024: 0.8×FY 2025: 1.7×
FY 2016 5y median 1.2× FY 2025
P/FCF -46.8×
FY 2016: 10.3×FY 2017: 13.9×FY 2018: 6.8×FY 2019: 7.2×FY 2020: -17.7×FY 2021: 149×FY 2022: -18.1×FY 2023: -55.0×FY 2024: 57.9×FY 2025: -46.8×
FY 2016 5y median -18.1× FY 2025
EV/EBITDA 12.4×
FY 2016: 7.2×FY 2017: 12.0×FY 2018: 3.6×FY 2019: -0.7×FY 2020: 1.4×FY 2021: 5.1×FY 2022: -2.5×FY 2023: 7.9×FY 2024: 6.5×FY 2025: 12.4×
FY 2016 5y median 6.5× FY 2025
EV/Sales 3.0×
FY 2016: 5.0×FY 2017: 7.3×FY 2018: 2.5×FY 2019: 0.5×FY 2020: 0.4×FY 2021: 1.6×FY 2022: 1.8×FY 2023: 1.4×FY 2024: 0.4×FY 2025: 3.0×
FY 2016 5y median 1.6× FY 2025
FCF Yield -2.1%
FY 2016: 9.7%FY 2017: 7.2%FY 2018: 14.6%FY 2019: 13.9%FY 2020: -5.7%FY 2021: 0.7%FY 2022: -5.5%FY 2023: -1.8%FY 2024: 1.7%FY 2025: -2.1%
FY 2016 5y median -1.8% FY 2025

Profitability

Gross Margin 68.8%
FY 2016: 68.7%FY 2017: 72.4%FY 2018: 81.5%FY 2019: 79.5%FY 2020: 77.7%FY 2021: 80.0%FY 2022: 68.2%FY 2023: 69.6%FY 2024: 65.3%FY 2025: 68.8%
FY 2016 5y median 68.8% FY 2025
Operating Margin 15.0%
FY 2016: 60.8%FY 2017: 53.4%FY 2018: 59.1%FY 2019: 48.4%FY 2020: 31.9%FY 2021: 25.4%FY 2022: -83.9%FY 2023: 8.7%FY 2024: -7.3%FY 2025: 15.0%
FY 2016 5y median 8.7% FY 2025
Net Margin 6.9%
FY 2016: 53.6%FY 2017: 52.8%FY 2018: 55.5%FY 2019: -95.7%FY 2020: 19.2%FY 2021: 13.7%FY 2022: -87.8%FY 2023: -2.9%FY 2024: -11.4%FY 2025: 6.9%
FY 2016 5y median -2.9% FY 2025
ROE 3.0%
FY 2016: 15.7%FY 2017: 13.1%FY 2018: 12.9%FY 2019: -28.7%FY 2020: 5.2%FY 2021: 5.0%FY 2022: -40.4%FY 2023: -1.2%FY 2024: -5.0%FY 2025: 3.0%
FY 2016 5y median -1.2% FY 2025
ROIC 2.1%
FY 2016: 14.0%FY 2017: 12.1%FY 2018: 12.4%FY 2019: 15.1%FY 2020: 5.7%FY 2021: 3.4%FY 2022: -20.6%FY 2023: 2.1%FY 2024: -1.9%FY 2025: 2.1%
FY 2016 5y median 2.1% FY 2025
ROA 1.5%
FY 2016: 14.0%FY 2017: 10.7%FY 2018: 10.5%FY 2019: -21.9%FY 2020: 3.6%FY 2021: 2.9%FY 2022: -15.8%FY 2023: -0.5%FY 2024: -2.1%FY 2025: 1.5%
FY 2016 5y median -0.5% FY 2025

Growth (YoY)

Revenue 34.2%
FY 2016: 0.6%FY 2017: -13.8%FY 2018: 6.2%FY 2019: -1.3%FY 2020: -14.4%FY 2021: 23.3%FY 2022: -28.2%FY 2023: -14.7%FY 2024: 2.2%FY 2025: 34.2%
FY 2016 FY 2025
Operating Income 376.8%
FY 2016: -6.7%FY 2017: -24.3%FY 2018: 17.7%FY 2019: -19.1%FY 2020: -43.6%FY 2021: -1.9%FY 2022: -337.2%FY 2023: 108.8%FY 2024: -185.4%FY 2025: 376.8%
FY 2016 FY 2025
EPS (diluted) 180.8%
FY 2016: -15.0%FY 2017: -11.8%FY 2018: 13.3%FY 2019: -270.6%FY 2020: 118.5%FY 2021: -18.2%FY 2022: -578.4%FY 2023: 97.2%FY 2024: -303.4%FY 2025: 180.8%
FY 2016 FY 2025
Free Cash Flow -479.2%
FY 2016: 53.4%FY 2017: -14.9%FY 2018: 1.3%FY 2019: -40.1%FY 2020: -130.5%FY 2021: 123.0%FY 2022: -653.8%FY 2023: 73.1%FY 2024: 160.0%FY 2025: -479.2%
FY 2016 FY 2025

Financial Health

Current Ratio 1.8×
FY 2016: 5.0×FY 2017: 2.5×FY 2018: 2.6×FY 2019: 2.8×FY 2020: 2.6×FY 2021: 3.1×FY 2022: 2.6×FY 2023: 1.5×FY 2024: 1.7×FY 2025: 1.8×
FY 2016 5y median 1.8× FY 2025
Quick Ratio 1.6×
FY 2016: 4.8×FY 2017: 2.4×FY 2018: 2.4×FY 2019: 2.6×FY 2020: 2.4×FY 2021: 2.8×FY 2022: 2.3×FY 2023: 1.4×FY 2024: 1.6×FY 2025: 1.6×
FY 2016 5y median 1.6× FY 2025
Debt / Equity 0.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.3×FY 2023: 0.3×FY 2024: 0.2×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA -4.4×
FY 2016: -1.1×FY 2017: -0.5×FY 2018: -1.6×FY 2019: 2.5×FY 2020: -5.1×FY 2021: -4.7×FY 2022: 1.6×FY 2023: -7.9×FY 2024: -25.2×FY 2025: -4.4×
FY 2016 5y median -4.7× FY 2025
Interest Coverage 1.9×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 284×FY 2019: 296×FY 2020: 95.8×FY 2021: 6.6×FY 2022: -8.7×FY 2023: 0.6×FY 2024: -0.5×FY 2025: 1.9×
FY 2016 5y median 0.6× FY 2025

Dividends

Dividend Yield 0.9%
FY 2016: 3.3%FY 2017: 5.5%FY 2018: 2.3%FY 2019: 2.4%FY 2020: 28.7%FY 2021: 1.3%FY 2022: 20.4%FY 2023: 5.7%FY 2024: 5.3%FY 2025: 0.9%
FY 2016 5y median 5.3% FY 2025
Payout Ratio 51.9%
FY 2016: 35.5%FY 2017: 79.0%FY 2018: 14.8%FY 2019: -5.8%FY 2020: 299.9%FY 2021: 29.5%FY 2022: -68.7%FY 2023: -552.7%FY 2024: -81.7%FY 2025: 51.9%
FY 2016 5y median -68.7% FY 2025

Annual · latest fiscal year ends 2025-12-31